Skip to main content
Top
Gepubliceerd in: Quality of Life Research 5/2023

03-08-2022 | Special Section: Methodologies for Meaningful Change

Likely change indexes improve estimates of individual change on patient-reported outcomes

Auteurs: John Devin Peipert, Ron D. Hays, David Cella

Gepubliceerd in: Quality of Life Research | Uitgave 5/2023

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Individual change on a patient-reported outcome (PRO) measure can be assessed by statistical significance and meaningfulness to patients. We explored the relationship between these two criteria by varying the confidence levels of the coefficient of repeatability (CR) on the Patient-Reported Outcomes Measurement Information System (R) Physical Function (PF) 10a (PF10a) measure.

Methods

In a sample of 1129 adult cancer patients, we estimated individual-change thresholds on the PF10a from baseline to 6 weeks later with the CR at 50%, 68%, and 95% confidence. We also assessed agreement with group- and individual-level thresholds from anchor-based methods [mean change and receiver operating characteristic (ROC) curve] using a PF-specific patient global impression of change (PGIC).

Results

CRs at 50%, 68%, and 95% confidence were 3, 4, and 7 raw score points, respectively. The ROC- and mean-change-based thresholds for deterioration were −4 and −6; for improvement they were both 2. Kappas for agreement between anchor-based thresholds and CRs for deterioration ranged between κ = 0.65 and 1.00, while for improvement, they ranged between 0.35 and 0.83. Agreement between the PGIC and all CRs always fell below “good” (κ < 0.40) for deterioration (0.30–0.33) and were lower for improvement (0.16–0.28).

Conclusions

In comparison to the CR at 95% confidence, CRs at 50% and 68% confidence (considered likely change indexes) have the advantage of maximizing the proportion of patients appropriately classified as changed according to statistical significance and meaningfulness.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference McNemar, Q. (1958). On growth measurement. Educational and Psychological Measurement, 18(1), 47–55.CrossRef McNemar, Q. (1958). On growth measurement. Educational and Psychological Measurement, 18(1), 47–55.CrossRef
2.
go back to reference Lord, F. M. (1956). The measurement of growth. Educational and Psychological Measurement, 16(4), 421–437.CrossRef Lord, F. M. (1956). The measurement of growth. Educational and Psychological Measurement, 16(4), 421–437.CrossRef
3.
go back to reference Cronbach, L. J., & Furby, L. (1970). How we should measure “change”: Or should we? Psychological Bulletin, 74(1), 68–80.CrossRef Cronbach, L. J., & Furby, L. (1970). How we should measure “change”: Or should we? Psychological Bulletin, 74(1), 68–80.CrossRef
4.
go back to reference US Food and Drug Administration. (2019). Discussion document for patient-focused drug development public workshop on guidance 4: Incorporating clinical outcome assessments into endpoints for regulatory decision-making. Silver Spring, MD: United States Department of Health and Human Services. US Food and Drug Administration. (2019). Discussion document for patient-focused drug development public workshop on guidance 4: Incorporating clinical outcome assessments into endpoints for regulatory decision-making. Silver Spring, MD: United States Department of Health and Human Services.
5.
go back to reference Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J. S., Terluin, B., Cella, D., Griffith, P., & Mokkink, L. B. (2021). Minimal important change (MIC): A conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of Life Research, 30(10), 2729–2754.CrossRefPubMedPubMedCentral Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J. S., Terluin, B., Cella, D., Griffith, P., & Mokkink, L. B. (2021). Minimal important change (MIC): A conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of Life Research, 30(10), 2729–2754.CrossRefPubMedPubMedCentral
6.
go back to reference Terluin, B., Eekhout, I., & Terwee, C. B. (2017). The anchor-based minimal important change, based on receiver operating characteristic analysis or predictive modeling, may need to be adjusted for the proportion of improved patients. Journal of Clinical Epidemiology, 83, 90–100.CrossRefPubMed Terluin, B., Eekhout, I., & Terwee, C. B. (2017). The anchor-based minimal important change, based on receiver operating characteristic analysis or predictive modeling, may need to be adjusted for the proportion of improved patients. Journal of Clinical Epidemiology, 83, 90–100.CrossRefPubMed
7.
go back to reference Terluin, B., Eekhout, I., Terwee, C. B., & de Vet, H. C. (2015). Minimal important change (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis. Journal of Clinical Epidemiology, 68(12), 1388–1396.CrossRefPubMed Terluin, B., Eekhout, I., Terwee, C. B., & de Vet, H. C. (2015). Minimal important change (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis. Journal of Clinical Epidemiology, 68(12), 1388–1396.CrossRefPubMed
8.
go back to reference Norman, G. R., Stratford, P., & Regehr, G. (1997). Methodological problems in the retrospective computation of responsiveness to change: The lesson of Cronbach. Journal of Clinical Epidemiology, 50(8), 869–879.CrossRefPubMed Norman, G. R., Stratford, P., & Regehr, G. (1997). Methodological problems in the retrospective computation of responsiveness to change: The lesson of Cronbach. Journal of Clinical Epidemiology, 50(8), 869–879.CrossRefPubMed
9.
go back to reference Hays, R. D., & Peipert, J. D. (2018). Minimally important differences do not identify responders to treatment. JOJ Sciences, 1(1). Hays, R. D., & Peipert, J. D. (2018). Minimally important differences do not identify responders to treatment. JOJ Sciences, 1(1).
10.
go back to reference Hays, R. D., Brodsky, M., Johnston, M. F., Spritzer, K. L., & Hui, K. K. (2005). Evaluating the statistical significance of health-related quality-of-life change in individual patients. Evaluation and the Health Professions, 28(2), 160–171.CrossRefPubMed Hays, R. D., Brodsky, M., Johnston, M. F., Spritzer, K. L., & Hui, K. K. (2005). Evaluating the statistical significance of health-related quality-of-life change in individual patients. Evaluation and the Health Professions, 28(2), 160–171.CrossRefPubMed
11.
go back to reference Moinpour, C. M., Donaldson, G. W., Davis, K. M., Potosky, A. L., Jensen, R. E., Gralow, J. R., Back, A. L., Hwang, J. J., Yoon, J., Bernard, D. L., Loeffler, D. R., Rothrock, N. E., Hays, R. D., Reeve, B. B., Smith, A. W., Hahn, E. A., & Cella, D. (2017). The challenge of measuring intra-individual change in fatigue during cancer treatment. Quality of Life Research, 26(2), 259–271.CrossRefPubMed Moinpour, C. M., Donaldson, G. W., Davis, K. M., Potosky, A. L., Jensen, R. E., Gralow, J. R., Back, A. L., Hwang, J. J., Yoon, J., Bernard, D. L., Loeffler, D. R., Rothrock, N. E., Hays, R. D., Reeve, B. B., Smith, A. W., Hahn, E. A., & Cella, D. (2017). The challenge of measuring intra-individual change in fatigue during cancer treatment. Quality of Life Research, 26(2), 259–271.CrossRefPubMed
12.
go back to reference King, M. T., Dueck, A. C., & Revicki, D. A. (2019). Can methods developed for interpreting group-level patient-reported outcome data be applied to individual patient management? Medical Care, 57, S38–S45.CrossRefPubMedPubMedCentral King, M. T., Dueck, A. C., & Revicki, D. A. (2019). Can methods developed for interpreting group-level patient-reported outcome data be applied to individual patient management? Medical Care, 57, S38–S45.CrossRefPubMedPubMedCentral
13.
go back to reference Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59(1), 12–19.CrossRefPubMed Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59(1), 12–19.CrossRefPubMed
14.
go back to reference Cella, D., Bullinger, M., Scott, C., & Barofsky, I. (2002). Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings, 77(4), 384–392.CrossRefPubMed Cella, D., Bullinger, M., Scott, C., & Barofsky, I. (2002). Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings, 77(4), 384–392.CrossRefPubMed
15.
go back to reference Donaldson, G. (2008). Patient-reported outcomes and the mandate of measurement. Quality of Life Research, 17(10), 1303–1313.CrossRefPubMed Donaldson, G. (2008). Patient-reported outcomes and the mandate of measurement. Quality of Life Research, 17(10), 1303–1313.CrossRefPubMed
16.
go back to reference Lee, M. K., Schalet, B. D., Cella, D., Yost, K. J., Dueck, A. C., Novotny, P. J., & Sloan, J. A. (2020). Establishing a common metric for patient-reported outcomes in cancer patients: Linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Patient Rep Outcomes, 4(1), 106.CrossRefPubMedPubMedCentral Lee, M. K., Schalet, B. D., Cella, D., Yost, K. J., Dueck, A. C., Novotny, P. J., & Sloan, J. A. (2020). Establishing a common metric for patient-reported outcomes in cancer patients: Linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Patient Rep Outcomes, 4(1), 106.CrossRefPubMedPubMedCentral
17.
go back to reference Jensen, R. E., Potosky, A. L., Reeve, B. B., Hahn, E., Cella, D., Fries, J., Smith, A. W., Keegan, T. H. M., Wu, X.-C., Paddock, L., & Moinpour, C. M. (2015). Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Quality of Life Research, 24(10), 2333–2344.CrossRefPubMedPubMedCentral Jensen, R. E., Potosky, A. L., Reeve, B. B., Hahn, E., Cella, D., Fries, J., Smith, A. W., Keegan, T. H. M., Wu, X.-C., Paddock, L., & Moinpour, C. M. (2015). Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Quality of Life Research, 24(10), 2333–2344.CrossRefPubMedPubMedCentral
18.
go back to reference Wahl, E., Gross, A., Chernitskiy, V., Trupin, L., Gensler, L., Chaganti, K., Michaud, K., Katz, P., & Yazdany, J. (2017). Validity and responsiveness of a 10-item patient-reported measure of physical function in a rheumatoid arthritis clinic population. Arthritis Care & Research, 69(3), 338–346.CrossRef Wahl, E., Gross, A., Chernitskiy, V., Trupin, L., Gensler, L., Chaganti, K., Michaud, K., Katz, P., & Yazdany, J. (2017). Validity and responsiveness of a 10-item patient-reported measure of physical function in a rheumatoid arthritis clinic population. Arthritis Care & Research, 69(3), 338–346.CrossRef
19.
go back to reference Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5(6), 649–655.CrossRefPubMed Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5(6), 649–655.CrossRefPubMed
20.
go back to reference Hays, R. D., & Peipert, J. D. (2021). Between-group minimally important change versus individual treatment responders. Quality of Life Research, 30(10), 2765–2772.CrossRefPubMedPubMedCentral Hays, R. D., & Peipert, J. D. (2021). Between-group minimally important change versus individual treatment responders. Quality of Life Research, 30(10), 2765–2772.CrossRefPubMedPubMedCentral
23.
go back to reference Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20(1), 37–46.CrossRef Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20(1), 37–46.CrossRef
24.
go back to reference Fleiss, J. L., Levin, B., & Paik, M. C. (2004). The measurement of interrater agreement. In Statistical methods for rates and proportions (pp. 598–626). John Wiley & Sons, Inc. Fleiss, J. L., Levin, B., & Paik, M. C. (2004). The measurement of interrater agreement. In Statistical methods for rates and proportions (pp. 598–626). John Wiley & Sons, Inc.
25.
go back to reference Terwee, C. B., Terluin, B., Knol, D. L., & de Vet, H. C. W. (2011). Combining clinical relevance and statistical significance for evaluating quality of life changes in the individual patient. Journal of Clinical Epidemiology, 64(12), 1465–1467.CrossRefPubMed Terwee, C. B., Terluin, B., Knol, D. L., & de Vet, H. C. W. (2011). Combining clinical relevance and statistical significance for evaluating quality of life changes in the individual patient. Journal of Clinical Epidemiology, 64(12), 1465–1467.CrossRefPubMed
26.
go back to reference Terwee, C. B., Roorda, L. D., Knol, D. L., De Boer, M. R., & De Vet, H. C. W. (2009). Linking measurement error to minimal important change of patient-reported outcomes. Journal of Clinical Epidemiology, 62(10), 1062–1067.CrossRefPubMed Terwee, C. B., Roorda, L. D., Knol, D. L., De Boer, M. R., & De Vet, H. C. W. (2009). Linking measurement error to minimal important change of patient-reported outcomes. Journal of Clinical Epidemiology, 62(10), 1062–1067.CrossRefPubMed
27.
go back to reference US Food and Drug Administration. (2009). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. Rockville, MD: US Department of Health and Human Services. US Food and Drug Administration. (2009). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. Rockville, MD: US Department of Health and Human Services.
28.
go back to reference US Food and Drug Administration. (2018). Discussion document for patient-focused drug development public workshop on guidance 3: Select, develop or modify fit-for-purpose clinical outcome assessments. Silver Spring, MD: United States Department of Health and Human Services. US Food and Drug Administration. (2018). Discussion document for patient-focused drug development public workshop on guidance 3: Select, develop or modify fit-for-purpose clinical outcome assessments. Silver Spring, MD: United States Department of Health and Human Services.
29.
go back to reference Coon, C. D., & Cook, K. F. (2018). Moving from significance to real-world meaning: Methods for interpreting change in clinical outcome assessment scores. Quality of Life Research, 27(1), 33–40.CrossRefPubMed Coon, C. D., & Cook, K. F. (2018). Moving from significance to real-world meaning: Methods for interpreting change in clinical outcome assessment scores. Quality of Life Research, 27(1), 33–40.CrossRefPubMed
30.
go back to reference Nunnally, J. C. (1978). Psychometric theory (2nd ed.). McGraw-Hill. Nunnally, J. C. (1978). Psychometric theory (2nd ed.). McGraw-Hill.
31.
go back to reference Segawa, E., Schalet, B., & Cella, D. (2020). A comparison of computer adaptive tests (CATs) and short forms in terms of accuracy and number of items administrated using PROMIS profile. Quality of Life Research, 29(1), 213–221.CrossRefPubMed Segawa, E., Schalet, B., & Cella, D. (2020). A comparison of computer adaptive tests (CATs) and short forms in terms of accuracy and number of items administrated using PROMIS profile. Quality of Life Research, 29(1), 213–221.CrossRefPubMed
32.
go back to reference Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., Devellis, R., DeWalt, D., Fries, J. F., Gershon, R., Hahn, E. A., Lai, J. S., Pilkonis, P., Revicki, D., & Goup, P. C. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol, 63(11), 1179–1194.CrossRefPubMedPubMedCentral Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., Devellis, R., DeWalt, D., Fries, J. F., Gershon, R., Hahn, E. A., Lai, J. S., Pilkonis, P., Revicki, D., & Goup, P. C. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol, 63(11), 1179–1194.CrossRefPubMedPubMedCentral
33.
go back to reference Terluin, B., Griffiths, P., van der Wouden, J. C., Ingelsrud, L. H., & Terwee, C. B. (2020). Unlike ROC analysis, a new IRT method identified clinical thresholds unbiased by disease prevalence. Journal of Clinical Epidemiology, 124, 118–125.CrossRefPubMed Terluin, B., Griffiths, P., van der Wouden, J. C., Ingelsrud, L. H., & Terwee, C. B. (2020). Unlike ROC analysis, a new IRT method identified clinical thresholds unbiased by disease prevalence. Journal of Clinical Epidemiology, 124, 118–125.CrossRefPubMed
34.
go back to reference Fayers, P. M., & Hays, R. D. (2014). Don’t middle your MIDs: Regression to the mean shrinks estimates of minimally important differences. Quality of Life Research, 23(1), 1–4.CrossRefPubMed Fayers, P. M., & Hays, R. D. (2014). Don’t middle your MIDs: Regression to the mean shrinks estimates of minimally important differences. Quality of Life Research, 23(1), 1–4.CrossRefPubMed
Metagegevens
Titel
Likely change indexes improve estimates of individual change on patient-reported outcomes
Auteurs
John Devin Peipert
Ron D. Hays
David Cella
Publicatiedatum
03-08-2022
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 5/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-022-03200-4

Andere artikelen Uitgave 5/2023

Quality of Life Research 5/2023 Naar de uitgave